WO1993018146A3 - Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques - Google Patents

Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques Download PDF

Info

Publication number
WO1993018146A3
WO1993018146A3 PCT/FR1993/000219 FR9300219W WO9318146A3 WO 1993018146 A3 WO1993018146 A3 WO 1993018146A3 FR 9300219 W FR9300219 W FR 9300219W WO 9318146 A3 WO9318146 A3 WO 9318146A3
Authority
WO
WIPO (PCT)
Prior art keywords
chaperones
ligands
fragments
preparation
forming complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1993/000219
Other languages
English (en)
Other versions
WO1993018146A2 (fr
Inventor
Marie-Claire Lebeau
Nelly Massol
Michel Renoir
Christine Radanyi
Jean-Paul Mornon
Isabelle Callebaut
Etienne-Emile Baulieu
Beatrice Chambraud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of WO1993018146A2 publication Critical patent/WO1993018146A2/fr
Publication of WO1993018146A3 publication Critical patent/WO1993018146A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention vise des séquences de nucléotides capables de s'hybrider avec la séquence de nucléotides représentée sur la figure 1, ainsi que les séquences d'acides aminés codées correspondantes. Ces séquences de nucléotides sont utiles notamment pour la détection de séquences complémentaires dans des échantillons biologiques.
PCT/FR1993/000219 1992-03-04 1993-03-04 Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques Ceased WO1993018146A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9202612A FR2688227A1 (fr) 1992-03-04 1992-03-04 Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
FR92/02612 1992-03-04

Publications (2)

Publication Number Publication Date
WO1993018146A2 WO1993018146A2 (fr) 1993-09-16
WO1993018146A3 true WO1993018146A3 (fr) 1993-11-11

Family

ID=9427364

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1993/000219 Ceased WO1993018146A2 (fr) 1992-03-04 1993-03-04 Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques

Country Status (2)

Country Link
FR (1) FR2688227A1 (fr)
WO (1) WO1993018146A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968720B2 (en) 2008-03-20 2015-03-03 University Of Miami Heat shock protein GP96 vaccination and methods of using same
US9238064B2 (en) 2008-03-03 2016-01-19 University Of Miami Allogeneic cancer cell-based immunotherapy

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5646249A (en) * 1994-02-28 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Isolation and characterization of a novel chaperone protein
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
AU3761695A (en) * 1994-10-14 1996-05-06 Salk Institute For Biological Studies, The Novel immunophilins and corresponding nucleic acids
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
BR9711499A (pt) * 1996-09-18 1999-08-24 Zetesis Spa Uso de prote¡nas como agentes contra doen-as auto-imunes
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
ES2439014T3 (es) 1998-02-20 2014-01-21 The University Of Miami Complejo de péptido antigénico-proteína de choque térmico modificada
DE19907598A1 (de) * 1999-02-22 2000-08-24 Schulz Burkhard DNA Sequenz kodierend ein FKBP ähnliches Protein, Plasmide, Bakterien, Hefen und Pflanzen enthaltend dieses Protein sowie Mutanten in Arabidopsis für dieses Gen, die in der Ausprägung der Pflanzenarchitektur, der Reaktion gegenüber Brassinosteroiden und ihren Verbindungen und durch Ethylen vermittelten Gravitropismus der Wurzel defekt sind
US6335157B1 (en) * 1999-05-07 2002-01-01 The European Molecular Biology Laboratory Method based on localization of Hsp90 to the centrosome
WO2001091787A1 (fr) 2000-06-02 2001-12-06 University Of Connecticut Health Center Complexes d'alpha (2) macroglobuline et de molecules antigeniques a utiliser en immunotherapie
RU2335295C2 (ru) 2001-08-20 2008-10-10 Юниверсити Оф Коннектикут Хелт Сентер Способы получения композиций, включающих хитшоковые белки или альфа-2-макроглобулин, пригодных для лечения злокачественной опухоли и инфекционного заболевания
KR20170109582A (ko) 2015-02-06 2017-09-29 히트 바이오로직스, 인코퍼레이티드 벡터 공동 발현 백신 및 공동 자극 분자
US11666649B2 (en) 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
CA3058938A1 (fr) 2017-04-04 2018-10-11 Heat Biologics, Inc. Vaccination intratumorale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004321A1 (fr) * 1989-09-25 1991-04-04 President And Fellows Of Harvard College Recepteur pour fk-506
WO1992001052A1 (fr) * 1990-07-11 1992-01-23 Tonen Corporation Adn codant pour une proteine de liaison de fk506 humaine et expression de cet adn

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004321A1 (fr) * 1989-09-25 1991-04-04 President And Fellows Of Harvard College Recepteur pour fk-506
WO1992001052A1 (fr) * 1990-07-11 1992-01-23 Tonen Corporation Adn codant pour une proteine de liaison de fk506 humaine et expression de cet adn

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOCHEMISTRY. vol. 29, no. 21, 1990, EASTON, PA US pages 5145 - 5152 SANCHEZ R. ET AL. 'The 56-59-kilodalton protein identified in untransformed receptor complexes is...' cité dans la demande *
GENBANK DATABASE,BETHESDA US Acc.No.x17069,Nelki S. al.:'Identification and DNA sequence of a family of related cDNA's one of which is haploid specific and...' *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9238064B2 (en) 2008-03-03 2016-01-19 University Of Miami Allogeneic cancer cell-based immunotherapy
US8968720B2 (en) 2008-03-20 2015-03-03 University Of Miami Heat shock protein GP96 vaccination and methods of using same

Also Published As

Publication number Publication date
WO1993018146A2 (fr) 1993-09-16
FR2688227A1 (fr) 1993-09-10

Similar Documents

Publication Publication Date Title
WO1993018146A3 (fr) Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques
CA2263889A1 (fr) Proteines ligands de p-selectine
EP1970386A8 (fr) Immunoglobulines hybrides
CA2177827A1 (fr) Nouvelles proteines modulant l'apoptose, adn codant pour ces proteines, et leur mode d'utilisation
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
EP0258411A4 (fr) Adn codant la streptavidine, spreptavidine ainsi produite, polypeptides fusionnes comprenant des sequences d'acides amines presents dans la streptavidine et leurs utilisations.
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
EP1013760A3 (fr) Produits stables de la protéine bactéricide augmentant la perméabilité et compositions thérapeutiques les contenant
WO2000006738A3 (fr) Acides nucleiques et proteines de streptococcus pneumoniae
CA2177357A1 (fr) Macromolecules chimeres pna-dna-pna
CA2497857A1 (fr) Nouveau coordinat proteinique de type p-selectine
IL87647A0 (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
AU3865989A (en) Purified ubiquitin hydrolase, dna sequences encoding same, and its use in recovering polypeptides
IE960853L (en) Vascular anticoagulant proteins
WO1995030001A3 (fr) Nouvelle proteine ligand de p-selectine
CA2262465A1 (fr) La neuritine, un neurogene
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
IL88095A0 (en) Dna sequences,proteins and gene preparations
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
WO1998044134A3 (fr) Plasmides bacteriens
AU2043597A (en) Human taki dna encoding the same
AU6260796A (en) Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
AU8526691A (en) Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase